The invention generally relates to treatment of occluded body lumens. In particular, the present devices and method relate to removal of the occluding material from the blood vessels as well as other body lumens.
Atherosclerosis is a progressive disease. In this disease, lesions of the arteries are formed by accumulation of plaque and neointimal hyperplasia causing an obstruction of blood flow. Often plaque is friable and may dislodge naturally or during an endovascular procedure, vessel. leading to embolization of a downstream vessel.
Endovascular clearing procedures to reduce or remove the obstructions to restore luminal diameter allows for increased blood flow to normal levels are well known. Removing the plaque has the effect of removing diseased tissue and helps to reverse the disease. Maintaining luminal diameter for a period of time (several to many weeks) allows remodeling of the vessel from the previous pathological state to a more normal state. Finally, it is the goal of an endovascular therapy to prevent short term complications such as embolization or perforation of the vessel and long term complications such as ischemia from thrombosis or restenosis.
Various treatment modalities may help to accomplish treatment goals. In atherectomy, plaque is cut away, or excised. Various configurations are used including a rotating cylindrical shaver or fluted cutter. The devices may include shielding by a housing for safety. The devices may also remove debris via trapping the debris in the catheter, in a downstream filter, or aspirating the debris. In some cases, a burr may be used instead of a cutter, particularly to grind heavily calcified lesions into very small particle sizes. Aspiration may also be used with a burr-type atherectomy device.
Balloon angioplasty is another type of endovascular procedure. Balloon angioplasty expands and opens the artery by both displacing the plaque and compressing it. Balloon angioplasty is known to cause barotrauma to the vessel from the high pressures required to compress the plaque. This trauma leads to an unacceptably high rate of restenosis. Furthermore, this procedure may not be efficient for treatment of elastic-type plaque tissue, where such tissue can spring back to occlude the lumen.
When clearing such obstructions, it is desirable to protect the vessel wall or wall of the body lumen being cleared and to debulk substantially all of a lesion. In additional cases, the procedure that clears obstructions may also be coupled with placement of an implant within the lumen. For example, it may be desirable to deploy a stent to maintain potency of a vessel for a period of time and/or to achieve local drug delivery by having the stent elute a drug or other bioactive substance.
On their own, stents fail to perform well in the peripheral vasculature for a variety of reasons. A stent with the necessary structural integrity to supply sufficient radial force to reopen the artery often does not perform well in the harsh mechanical environment of the peripheral vasculature. For example, the peripheral vasculature encounters a significant amount of compression, torsion, extension, and bending. Such an environment may lead to stent failure (strut cracking, stent crushing, etc.) that eventually compromises the ability of the stent to maintain lumen diameter over the long-term. On the other hand, a stent that is able to withstand the harsh mechanical aspects of the periphery often will not supply enough radial force to open the vessel satisfactorily. In many cases, medical practitioners desire the ability to combine endovascular clearing procedures with stenting.
Accordingly, a need remains for devices that allow for improved atherectomy devices that clear materials from body lumens (such as blood vessels) where the device includes features to allow for a safe, efficient and controlled fashion of shaving or grinding material within the body lumen.
The invention provides devices, systems, and methods for cutting and removing occlusive material from a body lumen.
According to one aspect of the invention, a vascular device is proved comprising a catheter body sized and configured for advancement in the body lumen. The catheter body has a center axis and includes spaced apart proximal and distal ends. The vascular device also includes a cutter assembly having an outside diameter located at the distal end of the catheter body. The cutter assembly comprises a housing having at least one opening and a cutter having at least one helical cutting surface configured to rotate about the central axis relative to the housing to cut and convey the occlusive material from the body lumen proximally into the housing. The vascular device further includes a drive mechanism at the proximal end of the catheter body, and a torque shaft coupled to the drive mechanism and extending through the catheter body and coupled to the cutter to rotate the helical cutting blade about the center axis relative to the housing. The vascular device also includes a conveyor mechanism helically wound about the torque shaft in a direction common with the helical cutting blade to convey the occlusive material conveyed into the housing by the helical cutting blade further proximally along the catheter body for discharge without supplement of a vacuum pump. The vascular device further includes a deflecting mechanism at the proximal end of the catheter body for deflecting the distal end of the catheter body relative to the center axis of the catheter body.
According to another aspect of the invention, a method includes manipulating the proximal end of the catheter body to insert the distal end of the catheter body within the body lumen. The method also includes manipulating the proximal end of the catheter body to advance the distal end of the catheter body within the body lumen toward the occlusive material. The method also includes operating the drive mechanism to rotate the helical cutting surface about the central axis to cut and convey the occlusive material from the body lumen proximally into the housing and to convey the occlusive material conveyed into the housing by the helical cutting surface further proximally along the catheter body by the conveyor mechanism for discharge without supplement of a vacuum pump. The method includes operating the deflecting mechanism at the proximal end of the catheter body to deflect the distal end of the catheter body relative to the center axis of the catheter body. The method includes rotating the distal end of the catheter body when the distal end is deflected to sweep the cutter assembly in an arc about the center axis to cut occlusive material in a region larger than the outside diameter of the cutter assembly.
In representative embodiments, the distal end of the catheter body is advanced within a body lumen having a bifurcation, and/or within a tortuous body lumen, and/or within a body lumen subject to biomechanical stresses to restore patency to a lesion in the body lumen and/or to debulk a lesion in the body lumen.
Although the disclosure hereof is detailed and exact to enable those skilled in the art to practice the invention, the physical embodiments herein disclosed merely exemplify the invention, which may be embodied in other specific structure. While the preferred embodiment has been described, the details may be changed without departing from the invention, which is defined by the claims.
In another variation, the device 100 may have a catheter body that comprises a soft or flexible portion. In one variation, this soft or flexible portion may be on a single side of the device 100 to allow flexure of the device 100 to articulate the cutting head. The flexure may be obtained with a curved sheath, mandrel, or other means as known to those skilled in the art.
The device 100 may also include a vacuum source or pump 152 to assist in evacuation of debris created by operation of the device. Any number of pumps or vacuum sources may be used in combination with the device. For example, a peristaltic pump may be used to drive materials from the device and into a waste container.
It may be advantageous to rotatably couple the torque shaft to the drive unit electromagnetically, without physical contact. For example, the torque shaft 114 can have magnetic poles installed at the proximal end, within a tubular structure that is attached to the sheath around the torque shaft. The stationary portion of the motor can be built into a handle that surrounds the tubular structure. This allows the continuous aspiration through the sheath without the use of high speed rotating seals.
As shown in
The geometry of the cutter 108 and housing 104 can be used to tailor the desired degree of cutting. The housing 104 and orientation of the openings 106 can be used to limit the depth of cutting by the cutter 108. In addition, the distal end of the housing 104 may be domed shaped while the proximal end may have a cylindrical or other shape. For example, by creating larger windows 106 in the housing a larger portion of cutter 108 may be exposed and the rate of cutting increased (for a given rotation speed). By placing the cutting window 106 on a convex portion of the housing, the debulking effectiveness is much less sensitive to the alignment of the cutter housing to the lesion, than if the window were on the cylindrical portion of the housing. This is a key performance limitation of traditional directional atherectomy catheters. In addition, placement of the window on the convex portion of the housing creates a secant effect (as described below).
However, to even out the torque profile of the device when cutting, the cutter 108 is configured such that the number edges/cutting surfaces 112 of the flutes 110 that are aligned with the housing openings 106 does not vary throughout the rotational cycle. This prevents the catheter from being overloaded with torque spikes and cyclic torque variations due to multiple cutting edges/flutes engaging with tissue in synchrony. In other words, the length of the cutting surface 112 exposed through the openings 106 of the housing 104 remains the same or constant.
In the variation shown in
As shown in
By controlling the number of cutting edges 112 that are exposed through openings 106 in the housing 104, it is possible to control the relative amount of cutting engagement (both length of cutting and depth of cut, together which control the volume of tissue removed per unit rotation of the cutter). These features allow independent control of the maximum torque load imposed on the device 100. By carefully selecting the geometry of the flutes and or cutting edges 112 relative to the openings 106 in the housing, it is possible to further control the balance of torque. For example, the torque load imposed on the device is caused by the shearing of tissue when the cutter edge passes the rotationally distal edge of the window. If all cutter edges simultaneously shear, as for example when the number of housing windows is an even multiple of cutter edges, the torque varies cyclically with rotation of the cutter. By adjusting the number of cutters and windows so one is not an even multiple of the other (for example, by using 5 windows on the housing and 4 cutting edges on the cutter), it is possible to have a more uniform torque (tissue removal from shearing action) during each cycle of the cutter.
This feature permits decoupling of the device 100 and guidewire 128 by merely pulling the guidewire 128 out of the track 136 (as opposed to needing to remove the guidewire 128 from the length of the device 136). One benefit of such a feature is that the guidewire 128 may remain close to the site while being decoupled from the device 100. Accordingly, the surgeon can advance additional devices over the guidewire and to the site in a rapid fashion. This configuration allows for quick separation of the catheter from the wire and introduction of another catheter over the wire since most of the wire is outside of the catheter.
As shown in
torque shaft 114 and conveying member 118 extend along the length of the catheter.
In some variations, the conveying member 118 may be integral to the shaft 114 (such as by cutting the conveying member 118 into the torque shaft 114 or by extruding the torque shaft 114 directly with a helical groove or protrusion. In an additional variation as shown in
As noted above, the conveying member 118 can be wound in the same directional sense as the cutter 108 and in the same direction of rotation to effect aspiration of tissue debris. The impeller action of the cutter 108 moves the tissue debris from inside the housing 104 openings 106 into the torque shaft. The pitch of the cutting edges 112 may be matched in to that of the conveying member 118 to further optimize aspiration. Alternatively, the pitch of the conveying member 118 may be changed to increase the speed at which material moves once it enters the conveying member 118. As discussed herein, debris can be evacuated outside the body by the conveying member 118 action along the length of the catheter and with or without supplement of the vacuum 152 pump connected to the catheter handle. Alternatively, the debris may be accumulated in a reservoir within the device.
The device may also include a ferrule 116, as shown in
In one variation of the device, the housing 104 is connected to the catheter body 120 via the ferrule 116 and thus is static. The cutter 108 rotates relative to the housing 104 so the cutting surface 112 on the cutter 108 cooperates with openings 106 on the housing 104 to shear or cleave tissue and trap the tissue inside the housing so that it can be evacuated in a proximal direction using the impeller action of the helical flutes and vacuum from the torque shaft.
The ferrule 116 can have a distal bearing surface to bear against the proximal surface of the cutter 108 and keeps the cutter axially stable in the housing 104. It can be rigidly bonded/linked to the housing 104 using solder, brazing, welding, adhesives (epoxy), swaging, crimped, press-fit, screwed on, snap-locked or otherwise affixed. As shown, the ferrule 116 can have holes or other rough features that allow for joining with the catheter body. While adhesives and heat fusing may be employed in the construction, such features are not required. Often adhesives are unreliable for a small surface contact and heat fusing can cause the tube to degrade. The use of a mechanical locking ring 126 allows the cutting assembly 102 to be short. Such a feature is important for maximizing the flexibility of the distal section of the catheter as it is required to navigate tortuosity in blood vessels.
In another aspect of the invention, devices 100 can be adapted to steer to remove materials that are located towards a side of the body passage. Such devices may include a deflecting member that permits adjusting the orientation or offset of the cutter assembly 102 relative to a central axis of the device. In
The ability to steer the device 100 also allows for a sweeping motion when cutting occlusive material.
A number of variations to control the deflection of the device 100 are described herein. For example, as shown in
In addition, the shape of the housing 104 as well as the location of the windows 106 can be chosen so that when the device 100 is substantially aligned with the lesion, or engages it at less than some critical attack angle, it will cut effectively. However, when pivoted at an angle greater than the critical angle, the cutting edges or grinding element will not engage the lesion as shown in
As mentioned above, variations of the device 100 allow directional control of the cutting assembly 102. In those variations where a slidable, torqueable sheath advances relative to the catheter body 122 (either external or internal to the catheter body) that can be flexed at the distal end. With the sheath flexed the catheter tip is pointed in the direction of the flex and the degree of bias is affected by the amount of flex on the sheath. The sheath can be rotated about the catheter or vessel long axis to change the direction of the cutting assembly. Also, as noted above, this rotation can also effect a sweep of the cutting assembly 102 in an arc or a circle larger than a diameter of the cutter 102 (e.g. see
As shown in
In another variation of the device 100, as shown in
Additional components may be incorporated into the devices described herein. For example, it can be desirable to incorporate transducers into the distal region of the catheter to characterize the plaque or to assess plaque and wall thickness and vessel diameter for treatment planning; also, transducers may be desired to indicate the progression of debulking or proximity of cutter to vessel wall. For example, pressure sensors mounted on the catheter housing can sense the increase in contact force encountered in the event that the housing is pressed against the vessel wall. Temperature sensors can be used to detect vulnerable plaque. Ultrasound transducers can be used to image luminal area, plaque thickness or volume, and wall thickness. Optical coherence tomography can be used to make plaque and wall thickness measurements. Electrodes can be used for sensing the impedance of contacted tissue, which allows discrimination between types of plaque and also vessel wall. Electrodes can also be used to deliver impulses of energy, for example to assess innervation, to either stimulate or inactivate smooth muscle, or to characterize the plaque (composition, thickness, etc.). For example, transient spasm may be introduced to bring the vessel to a smaller diameter easier to debulk, then reversed either electrically or pharmaceutically. Electrical energy may also be delivered to improve the delivery of drugs or biologic agents, by causing the cell membrane to open in response to the electric stimulation (electroporation). One method of characterization by electrical measurement is electrical impedance tomography.
As shown in
Infusing solutions (flush) into the target treatment site may be desirable. Infused cool saline can prevent heating of blood and other tissue, which reduces the possibility of thrombus or other tissue damage. Heparinized saline can also prevent thrombus and thin out the blood to help maximize effectiveness of aspiration. The flush can also include drugs such as Rapamycin, Paclitaxel or other restenosis-inhibitors. This may help to prevent restenosis and may result in better long term patency. The flush may include paralytics or long-acting smooth muscle relaxants to prevent acute recoil of the vessel.
Another way to infuse fluid is to supply pressurized fluid at the proximal portion of the guidewire lumen (gravity or pressure feed) intravenous bag, for example. A hemostatic seal with a side branch is useful for this purpose; tuohy-borst adapters are one example of a means to implement this.
Balancing the relative amount of infusion versus fluid volume aspirated allows control over the vessel diameter; aspirating more fluid than is instilled will evacuate the vessel, shrinking its diameter, and allow cutting of lesion at a greater diameter and allow than the atherectomy catheter. This has been a problem for certain open cutter designs that use aspiration because the aggressive aspiration required to trap the embolic particles evacuates and collapses the artery around the cutter blades; this is both a performance issue because the cutter can bog down from too high torque load, and the cutter can easily perforate the vessel. The shielded design described here obviates both problems, and further requires less aggressive aspiration to be effective, giving a wider range of control to the user.
The devices of the present invention may also be used in conjunction with other structures placed in the body lumens. For example, as shown in
Additional Variations of systems include devices 100 having a cutting assembly 170 comprising spinning turbine-like coring cutter 172 as shown in
It is also possible to use the devices and methods described here to restore potency to arterial lesions in the coronary circulation and in the carotid circulation, both by debulking de novo lesions and by debulking in stent restenosis.
The devices and methods described herein also work particularly well in lesions that are challenging to treat with other methods: at bifurcations, in tortuous arteries, and in arteries which are subject to biomechanical stresses (such as in the knee or other joints).
In a further variation of the devices described here, the motor drive unit may be powered by a controller that varies the speed and torque supplied to the catheter to optimize cutting efficiency or to automatically orbit the cutter using variable speed with a fixed flexible distal length of catheter (or providing further orbiting control by controlling the length of the distal flexible section of the catheter).
It is also possible to use feedback control to operate the catheter in a vessel safe mode, so that the rate of cutting is decreased as the vessel wall is approached. This may be accomplished through speed control, or by reducing the degree to which the cutting blades penetrate above the housing window by retracting the cutter axially within the housing. Feedback variables could be by optical (infrared) or ultrasound transducer, or by other transducers (pressure, electrical impedance, etc.), or by monitoring motor performance. Feedback variables may also be used in safety algorithms to stop the cutter, for example in a torque overload situation.
The atherectomy catheter may be further configured with a balloon proximal to the cutter, for adjunctive angioplasty or stent delivery. The catheter may optionally be configured to deliver self-expanding stents. This provides convenience to the user and greater assurance of adjunctive therapy at the intended location where atherectomy was performed.
Further methods include use of similar devices to debulk stenosis in AV hemodialysis access sites (fistulae and synthetic grafts), as well as to remove thrombus. By removing the cutter housing and recessing the fluted cutter within the catheter sheath, a suitable non-cutting thrombectomy catheter may be constructed.
Other methods of use include excising bone, cartilage, connective tissue, or muscle during minimally invasive surgical procedures. For example, a catheter that includes cutting and burr elements may be used to gain access to the spine for performing laminectomy or facetectomy procedures to alleviate spinal stenosis. For this application, the catheter may be further designed to deploy through a rigid cannula over part of its length, or have a rigid portion itself, to aid in surgical insertion and navigation.
For this reason, it is advantageous to couple atherectomy with stenting. By removing material, debulking the lesion, a lesser radial force is required to further open the artery and maintain lumen diameter. The amount of debulking can be tuned to perform well in concert with the mechanical characteristics of the selected stent. For stents that supply greater expansion and radial force, relatively less atherectomy is required for satisfactory result. An alternative treatment approach is to debulk the lesion substantially, which will allow placement of a stent optimized for the mechanical conditions inherent in the peripheral anatomy. In essence, the stent can support itself against the vessel wall and supply mild radial force to preserve Lumina]. patency. The stent may be bioresorbable, and/or drug eluting, with the resorption or elution happening over a period for days to up to 12 weeks or more. A period of 4 to 2 weeks matches well with the time course of remodeling and return to stability as seen in the classic wound healing response, and in particular the known remodeling time course of arteries following stent procedures. In addition, the stent geometry can be optimized to minimize thrombosis by inducing swirl in the blood flow. This has the effect of minimizing or eliminating stagnant or recirculating flow that leads to thrombus formation. Spiral construction of at least the proximal (upstream) portion of the stein will achieve this. It is also beneficial to ensure that flow immediately distal to the stent does not create any stagnant or recirculation zones, and swirl is a way to prevent this also.
In a typical case of a total occlusion, it is also difficult if not impossible to visualize the lumen near the occlusion because any injected contrast agents cannot flow through the occlusion site.
The lumen-creating device 200 can optionally be made to have a shoulder 212 at its distal end, as shown in
Next, a guidewire can be used with a cutter assembly to remove some or all of the remaining mass in the vessel. Alternatively, the initial lumen made may be adequately large without further atherectomy. Technical success is typically less than 30 percent or less than 20 percent residual stenosis. Also, balloon angioplasty with or without stenting may be performed following establishment of a guidewire lumen with a support catheter and a lumen-creating catheter.
Contrast injection and aspiration ports near the distal end of the support circulate contrast agents, enabling the use of fluoroscopy to visualize the lumen adjacent to the total occlusion during diagnosis or treatment. The central lumen 202 of the support catheter 200 can also be used to inject or aspire the contrast agents 208. The contrast agents can circulate through the center lumen 202 in the support catheter 200 and at least one port 206 in various configurations. The fluid can circulate about the distal tip of the catheter, the motion of the fluid being circular as shown in
It is noted that the descriptions above are intended to provide exemplary embodiments of the devices and methods. It is understood that, the invention includes combinations of aspects of embodiments or combinations of the embodiments themselves. Such variations and combinations are within the scope of this disclosure.
The present application is a Continuation of U.S. application Ser. No. 14/532,802 filed Nov. 4, 2014 and entitled “Devices, Systems, and Methods for Cutting and Removing Occlusive Material from a Body Lumen,” which is a Continuation of U.S. application Ser. No. 12/925,466 filed Oct. 12, 2010 and entitled “Devices, Systems and Methods for Cutting and Removing Occlusive Material from a Body Lumen” now issued as U.S. Pat. No. 9,492,193, which is a Continuation of U.S. application Ser. No. 11/567,715 filed Dec. 6, 2006 and entitled “Atherectomy Devices and Methods” now issued as U.S. Pat. No. 8,361,094, which is a Continuation of U.S. application Ser. No. 11/551,191 filed Oct. 19, 2006 and entitled “Atherectomy Devices and Methods” now issued as U.S. Pat. No. 8,920,448, which claims the benefit of both U.S. Provisional Application Ser. No. 60/820,475 entitled “Atherectomy Device” filed Jul. 26, 2006 and U.S. Provisional Application Ser. No. 60/806,417 entitled “Atherectomy Device” filed Jun. 30, 2006 all of which are hereby incorporated reference.
Number | Name | Date | Kind |
---|---|---|---|
3358472 | Klipping | Dec 1967 | A |
4167944 | Banko | Sep 1979 | A |
4445509 | Auth | May 1984 | A |
4598710 | Kleinberg et al. | Jul 1986 | A |
4598716 | Hileman | Jul 1986 | A |
4631052 | Kensey | Dec 1986 | A |
4669469 | Gifford, III et al. | Jun 1987 | A |
4690140 | Mecca | Sep 1987 | A |
4696667 | Masch | Sep 1987 | A |
4770652 | Mahurkar | Sep 1988 | A |
4781186 | Simpson et al. | Nov 1988 | A |
4790812 | Hawkins, Jr. et al. | Dec 1988 | A |
4804364 | Dieras et al. | Feb 1989 | A |
4808153 | Parisi | Feb 1989 | A |
4844064 | Thimsen et al. | Jul 1989 | A |
4857045 | Rydell | Aug 1989 | A |
4857046 | Stevens et al. | Aug 1989 | A |
4867157 | McGurk-Burleson et al. | Sep 1989 | A |
4886490 | Shiber | Dec 1989 | A |
4887599 | Muller | Dec 1989 | A |
4894051 | Shiber | Jan 1990 | A |
4911148 | Sosnowski et al. | Mar 1990 | A |
4950277 | Farr | Aug 1990 | A |
4994067 | Summers | Feb 1991 | A |
4994087 | Konrad et al. | Feb 1991 | A |
5074841 | Ademovic et al. | Dec 1991 | A |
5100426 | Nixon | Mar 1992 | A |
5114399 | Kovalcheck | May 1992 | A |
5122134 | Borzone et al. | Jun 1992 | A |
5231989 | Middleman et al. | Aug 1993 | A |
5242461 | Kortenbach et al. | Sep 1993 | A |
5267955 | Hanson | Dec 1993 | A |
5282813 | Redha | Feb 1994 | A |
5282821 | Donahue | Feb 1994 | A |
5284128 | Hart | Feb 1994 | A |
5304189 | Goldberg et al. | Apr 1994 | A |
5312427 | Shturman | May 1994 | A |
5314438 | Shturman | May 1994 | A |
5320635 | Smith | Jun 1994 | A |
5332329 | Hill et al. | Jul 1994 | A |
5334211 | Shiber | Aug 1994 | A |
5356418 | Shturman | Oct 1994 | A |
5358472 | Vance et al. | Oct 1994 | A |
5360432 | Shturman | Nov 1994 | A |
5370609 | Drasler et al. | Dec 1994 | A |
5372587 | Hammerslag et al. | Dec 1994 | A |
5409454 | Fischell et al. | Apr 1995 | A |
5417703 | Brown et al. | May 1995 | A |
5423799 | Shiu | Jun 1995 | A |
5429604 | Hammersmark et al. | Jul 1995 | A |
5429617 | Hammersmark et al. | Jul 1995 | A |
5431173 | Shin et al. | Jul 1995 | A |
5456680 | Taylor et al. | Oct 1995 | A |
5474532 | Steppe | Dec 1995 | A |
5489291 | Wiley | Feb 1996 | A |
5501653 | Chin | Mar 1996 | A |
5520609 | Moll et al. | May 1996 | A |
5529580 | Kusunoki et al. | Jun 1996 | A |
5540706 | Aust et al. | Jul 1996 | A |
5554163 | Shturman | Sep 1996 | A |
5556408 | Farhat | Sep 1996 | A |
5569197 | Helmus et al. | Oct 1996 | A |
5569275 | Kotula et al. | Oct 1996 | A |
5584843 | Wulfman et al. | Dec 1996 | A |
5618294 | Aust et al. | Apr 1997 | A |
5626562 | Castro | May 1997 | A |
5632755 | Nordgren et al. | May 1997 | A |
5634178 | Sugiura et al. | May 1997 | A |
5634883 | Chin et al. | Jun 1997 | A |
5643178 | Moll et al. | Jul 1997 | A |
5643251 | Hillsman et al. | Jul 1997 | A |
5643297 | Nordgren et al. | Jul 1997 | A |
5643298 | Nordgren et al. | Jul 1997 | A |
5649941 | Lary | Jul 1997 | A |
5656562 | Wu | Aug 1997 | A |
5665062 | Houser | Sep 1997 | A |
5665098 | Kelly et al. | Sep 1997 | A |
5669926 | Aust et al. | Sep 1997 | A |
5690634 | Muller et al. | Nov 1997 | A |
5690643 | Wijay | Nov 1997 | A |
5695506 | Pike et al. | Dec 1997 | A |
5716327 | Warner et al. | Feb 1998 | A |
5725543 | Redha | Mar 1998 | A |
5728129 | Summers | Mar 1998 | A |
5733297 | Wang | Mar 1998 | A |
5743456 | Jones et al. | Apr 1998 | A |
5746758 | Nordgren et al. | May 1998 | A |
5755731 | Grinberg | May 1998 | A |
5766196 | Griffiths | Jun 1998 | A |
5772329 | Bardon et al. | Jun 1998 | A |
5779721 | Nash | Jul 1998 | A |
5782834 | Lucey et al. | Jul 1998 | A |
5820592 | Hammerslag | Oct 1998 | A |
5826582 | Sheehan et al. | Oct 1998 | A |
5828582 | Conklen et al. | Oct 1998 | A |
5843103 | Wulfman | Dec 1998 | A |
5851208 | Trott | Dec 1998 | A |
5851212 | Zirps et al. | Dec 1998 | A |
5865082 | Cote et al. | Feb 1999 | A |
5865098 | Anelli | Feb 1999 | A |
5873882 | Straub et al. | Feb 1999 | A |
5876414 | Straub | Mar 1999 | A |
5882329 | Patterson et al. | Mar 1999 | A |
5882333 | Schaer et al. | Mar 1999 | A |
5885098 | Witkowski | Mar 1999 | A |
5890643 | Razon et al. | Apr 1999 | A |
5895399 | Barbut et al. | Apr 1999 | A |
5895508 | Halow | Apr 1999 | A |
5897566 | Shturman et al. | Apr 1999 | A |
5902263 | Patterson et al. | May 1999 | A |
5902283 | Darouiche et al. | May 1999 | A |
5902313 | Redha | May 1999 | A |
5910150 | Saadat | Jun 1999 | A |
5941869 | Patterson et al. | Aug 1999 | A |
5941893 | Saadat | Aug 1999 | A |
6001112 | Taylor | Dec 1999 | A |
6015420 | Wulfman et al. | Jan 2000 | A |
6027450 | Brown et al. | Feb 2000 | A |
6027514 | Stine et al. | Feb 2000 | A |
6042593 | Storz et al. | Mar 2000 | A |
6048339 | Zirps et al. | Apr 2000 | A |
6053923 | Veca et al. | Apr 2000 | A |
6066153 | Lev | May 2000 | A |
6080170 | Nash et al. | Jun 2000 | A |
6086153 | Heidmann et al. | Jul 2000 | A |
6090118 | McGuckin, Jr. | Jul 2000 | A |
6132444 | Shturman et al. | Oct 2000 | A |
6139557 | Passafaro et al. | Oct 2000 | A |
6142955 | Farascioni et al. | Nov 2000 | A |
6146395 | Kanz et al. | Nov 2000 | A |
6152938 | Curry | Nov 2000 | A |
6156046 | Passafaro et al. | Dec 2000 | A |
6165209 | Patterson et al. | Dec 2000 | A |
6183487 | Barry et al. | Feb 2001 | B1 |
6206898 | Honeycutt et al. | Mar 2001 | B1 |
6237405 | Leslie | May 2001 | B1 |
6238405 | Findlay, III et al. | May 2001 | B1 |
6241744 | Imran et al. | Jun 2001 | B1 |
6258098 | Taylor et al. | Jul 2001 | B1 |
6264630 | Mickley et al. | Jul 2001 | B1 |
6284830 | Gottschalk et al. | Sep 2001 | B1 |
6299622 | Snow et al. | Oct 2001 | B1 |
6319242 | Patterson et al. | Nov 2001 | B1 |
6355027 | Le et al. | Mar 2002 | B1 |
6371928 | Mcfann et al. | Apr 2002 | B1 |
6406422 | Landesberg | Jun 2002 | B1 |
6406442 | McFann et al. | Jun 2002 | B1 |
6451036 | Heitzmann et al. | Sep 2002 | B1 |
6454779 | Taylor | Sep 2002 | B1 |
6482215 | Shiber | Nov 2002 | B1 |
6482217 | Pintor et al. | Nov 2002 | B1 |
6494890 | Shturman et al. | Dec 2002 | B1 |
6497711 | Plaia | Dec 2002 | B1 |
6554848 | Boylan et al. | Apr 2003 | B2 |
6562049 | Norlander et al. | May 2003 | B1 |
6565195 | Blair | May 2003 | B2 |
6565588 | Clement et al. | May 2003 | B1 |
6572630 | McGuckin, Jr. et al. | Jun 2003 | B1 |
6578851 | Bryant, III | Jun 2003 | B1 |
6579298 | Bruneau et al. | Jun 2003 | B1 |
6579299 | McGuckin, Jr. et al. | Jun 2003 | B2 |
6596005 | Kanz et al. | Jul 2003 | B1 |
6602264 | McGuckin, Jr. | Aug 2003 | B1 |
6620148 | Tsugita | Sep 2003 | B1 |
6623495 | Findlay, III et al. | Sep 2003 | B2 |
6629953 | Boyd | Oct 2003 | B1 |
6638233 | Corvi et al. | Oct 2003 | B2 |
6638288 | Shturman et al. | Oct 2003 | B1 |
RE38335 | Aust et al. | Nov 2003 | E |
6656195 | Peters et al. | Dec 2003 | B2 |
6658195 | Senshu et al. | Dec 2003 | B1 |
6666854 | Lange | Dec 2003 | B1 |
6666874 | Heitzmann et al. | Dec 2003 | B2 |
6682545 | Kester | Jan 2004 | B1 |
6702830 | Demarais et al. | Mar 2004 | B1 |
6746422 | Noriega et al. | Jun 2004 | B1 |
6758851 | Shiber | Jul 2004 | B2 |
6790215 | Findlay, III et al. | Sep 2004 | B2 |
6800085 | Selmon et al. | Oct 2004 | B2 |
6802284 | Hironaka et al. | Oct 2004 | B2 |
6808531 | Lafontaine et al. | Oct 2004 | B2 |
6818001 | Wulfman et al. | Nov 2004 | B2 |
6818002 | Shiber | Nov 2004 | B2 |
6830577 | Nash et al. | Dec 2004 | B2 |
6843797 | Nash et al. | Jan 2005 | B2 |
6860235 | Anderson et al. | Mar 2005 | B2 |
6866854 | Chang et al. | Mar 2005 | B1 |
6868854 | Kempe | Mar 2005 | B2 |
6876414 | Hara et al. | Apr 2005 | B2 |
6936056 | Nash et al. | Aug 2005 | B2 |
6997934 | Snow et al. | Feb 2006 | B2 |
7008375 | Weisel | Mar 2006 | B2 |
7025751 | Silva et al. | Apr 2006 | B2 |
7033357 | Baxter et al. | Apr 2006 | B2 |
7037316 | McGuckin, Jr. et al. | May 2006 | B2 |
RE39152 | Aust et al. | Jun 2006 | E |
7172810 | Hashimoto et al. | Feb 2007 | B2 |
7235088 | Pintor et al. | Jun 2007 | B2 |
7316697 | Shiber | Jan 2008 | B2 |
7344546 | Wulfman et al. | Mar 2008 | B2 |
7344548 | Toyota et al. | Mar 2008 | B2 |
7381198 | Noriega et al. | Jun 2008 | B2 |
7399307 | Evans et al. | Jul 2008 | B2 |
7479147 | Honeycutt et al. | Jan 2009 | B2 |
7534249 | Nash et al. | May 2009 | B2 |
7666161 | Nash et al. | Feb 2010 | B2 |
7875018 | Tockman et al. | Jan 2011 | B2 |
7879022 | Bonnette et al. | Feb 2011 | B2 |
7981128 | To et al. | Jul 2011 | B2 |
8007500 | Lin et al. | Aug 2011 | B2 |
8007506 | To et al. | Aug 2011 | B2 |
8015420 | Cherian et al. | Sep 2011 | B2 |
8070762 | Escudero et al. | Dec 2011 | B2 |
8236016 | To et al. | Aug 2012 | B2 |
8337516 | Escudero et al. | Dec 2012 | B2 |
8361094 | To et al. | Jan 2013 | B2 |
8469979 | Olson | Jun 2013 | B2 |
8517994 | Li et al. | Aug 2013 | B2 |
8545447 | Demarais et al. | Oct 2013 | B2 |
8568432 | Straub | Oct 2013 | B2 |
8572630 | Woundy et al. | Oct 2013 | B2 |
8579926 | Pintor et al. | Nov 2013 | B2 |
8585726 | Yoon et al. | Nov 2013 | B2 |
8628549 | To et al. | Jan 2014 | B2 |
8647355 | Escudero et al. | Feb 2014 | B2 |
8747350 | Chin et al. | Jun 2014 | B2 |
8876414 | Taniguchi et al. | Nov 2014 | B2 |
20010004700 | Honeycutt et al. | Jun 2001 | A1 |
20010005909 | Findlay et al. | Jun 2001 | A1 |
20020004680 | Plaia et al. | Jan 2002 | A1 |
20020007190 | Wulfman et al. | Jan 2002 | A1 |
20020029057 | McGuckin | Mar 2002 | A1 |
20020077842 | Charisius et al. | Jun 2002 | A1 |
20020151918 | Lafontaine et al. | Oct 2002 | A1 |
20020168467 | Puech | Nov 2002 | A1 |
20020169467 | Heitzmann et al. | Nov 2002 | A1 |
20020198550 | Nash et al. | Dec 2002 | A1 |
20030018346 | Follmer et al. | Jan 2003 | A1 |
20030078606 | Lafontaine et al. | Apr 2003 | A1 |
20030100911 | Nash et al. | May 2003 | A1 |
20030114869 | Nash et al. | Jun 2003 | A1 |
20030125758 | Simpson et al. | Jul 2003 | A1 |
20030139751 | Evans et al. | Jul 2003 | A1 |
20030139802 | Wulfman et al. | Jul 2003 | A1 |
20040006358 | Wulfman et al. | Jan 2004 | A1 |
20040087988 | Heitzmann et al. | May 2004 | A1 |
20040097995 | Nash et al. | May 2004 | A1 |
20040102772 | Baxter et al. | May 2004 | A1 |
20040103516 | Bolduc et al. | Jun 2004 | A1 |
20040147934 | Kiester | Jul 2004 | A1 |
20040167533 | Wilson et al. | Aug 2004 | A1 |
20040167553 | Simpson et al. | Aug 2004 | A1 |
20040167554 | Simpson et al. | Aug 2004 | A1 |
20040181249 | Torrance | Sep 2004 | A1 |
20040199051 | Weisel | Oct 2004 | A1 |
20040202772 | Matsuda et al. | Oct 2004 | A1 |
20040220519 | Wulfman et al. | Nov 2004 | A1 |
20040230212 | Wulfman | Nov 2004 | A1 |
20040230213 | Wulfman et al. | Nov 2004 | A1 |
20040235611 | Nistal | Nov 2004 | A1 |
20040236312 | Nistal et al. | Nov 2004 | A1 |
20040238312 | Sudau | Dec 2004 | A1 |
20040243162 | Wulfman et al. | Dec 2004 | A1 |
20050004585 | Hall et al. | Jan 2005 | A1 |
20050020974 | Noriega et al. | Jan 2005 | A1 |
20050059990 | Ayala et al. | Mar 2005 | A1 |
20050113853 | Noriega et al. | May 2005 | A1 |
20050149084 | Kanz et al. | Jul 2005 | A1 |
20050177068 | Simpson | Aug 2005 | A1 |
20050197661 | Carrison et al. | Sep 2005 | A1 |
20050197861 | Omori et al. | Sep 2005 | A1 |
20050222519 | Simpson | Oct 2005 | A1 |
20050240146 | Nash et al. | Oct 2005 | A1 |
20060020327 | Lashinski et al. | Jan 2006 | A1 |
20060074442 | Noriega et al. | Apr 2006 | A1 |
20060229646 | Sparks | Oct 2006 | A1 |
20060239982 | Simpson | Oct 2006 | A1 |
20060241564 | Corcoran et al. | Oct 2006 | A1 |
20070135733 | Soukup et al. | Jun 2007 | A1 |
20070225739 | Pintor et al. | Sep 2007 | A1 |
20070250000 | Magnin et al. | Oct 2007 | A1 |
20070282303 | Nash et al. | Dec 2007 | A1 |
20070282350 | Hernest | Dec 2007 | A1 |
20070282358 | Remiszewski et al. | Dec 2007 | A1 |
20080004643 | To et al. | Jan 2008 | A1 |
20080004644 | To et al. | Jan 2008 | A1 |
20080004645 | To et al. | Jan 2008 | A1 |
20080004646 | To et al. | Jan 2008 | A1 |
20080004647 | To et al. | Jan 2008 | A1 |
20080045986 | To et al. | Feb 2008 | A1 |
20080103516 | Wulfman et al. | May 2008 | A1 |
20080140101 | Carley et al. | Jun 2008 | A1 |
20080234715 | Pesce et al. | Sep 2008 | A1 |
20080249364 | Korner | Oct 2008 | A1 |
20090018565 | To et al. | Jan 2009 | A1 |
20090018566 | Escudero et al. | Jan 2009 | A1 |
20090018567 | Escudero et al. | Jan 2009 | A1 |
20090024085 | To et al. | Jan 2009 | A1 |
20090234378 | Escudero et al. | Sep 2009 | A1 |
20100010492 | Lockard et al. | Jan 2010 | A1 |
20100049225 | To et al. | Feb 2010 | A1 |
20100174302 | Heitzmann et al. | Jul 2010 | A1 |
20100324567 | Root et al. | Dec 2010 | A1 |
20100324576 | Pintor et al. | Dec 2010 | A1 |
20110040315 | To et al. | Feb 2011 | A1 |
20110112563 | To et al. | May 2011 | A1 |
20110152906 | Escudero et al. | Jun 2011 | A1 |
20110152907 | Escudero et al. | Jun 2011 | A1 |
20110270289 | To et al. | Nov 2011 | A1 |
20110301626 | To et al. | Dec 2011 | A1 |
20120083810 | Escudero et al. | Apr 2012 | A1 |
20130085515 | To et al. | Apr 2013 | A1 |
20130090674 | Escudero et al. | Apr 2013 | A1 |
20130096587 | Smith et al. | Apr 2013 | A1 |
20130103062 | To et al. | Apr 2013 | A1 |
20130103063 | Escudero et al. | Apr 2013 | A1 |
20130158578 | Ghodke et al. | Jun 2013 | A1 |
20130296901 | Olson | Nov 2013 | A1 |
20140039532 | Vrba | Feb 2014 | A1 |
20140058423 | Smith et al. | Feb 2014 | A1 |
20140107680 | Escudero et al. | Apr 2014 | A1 |
Number | Date | Country |
---|---|---|
0254414 | Jan 1988 | EP |
0817594 | Jan 1998 | EP |
0817595 | Jan 1998 | EP |
1158910 | Dec 2001 | EP |
1 178 315 | Feb 2002 | EP |
1176915 | Feb 2002 | EP |
1315460 | Jun 2003 | EP |
1722694 | Nov 2006 | EP |
1870044 | Dec 2007 | EP |
2 462 881 | Jun 2012 | EP |
2 641 551 | Sep 2013 | EP |
1-131653 | May 1989 | JP |
08-509639 | Oct 1996 | JP |
2006-511256 | Oct 1996 | JP |
09-508554 | Sep 1997 | JP |
11-506358 | Jun 1999 | JP |
2001-522631 | Nov 2001 | JP |
2002-538876 | Nov 2002 | JP |
2004-503265 | Feb 2004 | JP |
2004-514463 | May 2004 | JP |
9201423 | Feb 1992 | WO |
9214506 | Sep 1992 | WO |
9424946 | Nov 1994 | WO |
9521576 | Aug 1995 | WO |
9629941 | Oct 1996 | WO |
9629942 | Oct 1996 | WO |
9923958 | May 1999 | WO |
9935977 | Jul 1999 | WO |
0054659 | Sep 2000 | WO |
00054859 | Sep 2000 | WO |
0164115 | Sep 2001 | WO |
0174255 | Oct 2001 | WO |
0176680 | Oct 2001 | WO |
2005084562 | Sep 2005 | WO |
2005123169 | Dec 2005 | WO |
2007010389 | Jan 2007 | WO |
2008005888 | Jan 2008 | WO |
2008005891 | Jan 2008 | WO |
2009005779 | Jan 2009 | WO |
2009054968 | Apr 2009 | WO |
2009126309 | Oct 2009 | WO |
2013056262 | Apr 2013 | WO |
2013172970 | Nov 2013 | WO |
2015017114 | Feb 2015 | WO |
Entry |
---|
Extended European Search Report for Application No. 12840013.2 dated Aug. 25, 2015, 11 pages. |
Ikeno et al., 2004, “Initial Experience with the Novel 6 F r-Compatible System for Debulking De Novo Coronary Arterial Lesions,” Catheterization and Cardiovascular Interventions 62:308-17. |
International Preliminary Report on Patentability dated Jan. 6, 2009, for PCT Patent Application No. PCT/US2007/072570, filed on Jun. 29, 2007, 4 pages. |
International Preliminary Report on Patentability dated Jun. 30, 2010, for PCT Patent Application No. PCT/US2008/012012, filed on Oct. 22, 2008, 11 pages. |
International Preliminary Report on Patentability dated Jul. 22, 2010, for PCT Patent Application No. PCT/US2009/02253, filed on Apr. 10, 2009, 12 pages. |
International Preliminary Report on Patentability dated Aug. 6, 2010, for PCT Patent Application No. PCT/US2009/002253, filed on Apr. 10, 2009, 12 pages. |
International Search Report and Written Opinion, dated Feb. 10, 2015, for International Application PCT/US14/46432, filed Jul. 11, 2014, 10 pages. |
International Search Report dated Sep. 3, 2008, for PCT Patent Application No. PCT/US07/72570, filed on Jun. 29, 2007, 1 page. |
International Search Report dated Sep. 18, 2008, for PCT Patent Application No. PCT/US2007/072574, filed on Jun. 29, 2007, 1 page. |
International Search Report dated Oct. 29, 2008, for PCT Patent Application No. PCT/US08/08140, filed on Jun. 30, 2008, 1 page. |
International Search Report dated Feb. 12, 2009, for PCT Patent Application No. PCT/US08/12012, filed on Oct. 22, 2008, 1 page. |
International Search Report dated Aug. 12, 2009, for PCT Patent Application No. PCT/US09/02253, filed on Apr. 10, 2009, 1 page. |
International Search Report dated Mar. 12, 2013, for PCT Patent Application No. PCT/US12/60316, filed on Oct. 15, 2012, 5 pages. |
Kanjwal et al., 2004, “Peripheral Aiterial Disease—The Silent Killer,” JK-Practitioner 11(4):225-32. |
Nakamura et al., 2002, “Efficacy and Feasibility of Helixcision for Debulking Neointimal Hyperplasia for In-Stent Restenosis,” Catheterization and Cardiovascular Interventions 57:460-66. |
Supplementary European Search Report dated Jun. 20, 2011, for EP Patent Application No. 08779894.8, filed on Jun. 30, 2008, 7 pages. |
Supplementary European Search Report dated Jun. 26, 2013, for EP Patent Application No. 08841648.2, filed on May 21, 2010, 5 pages. |
Supplementary European Search Report dated Aug. 21, 2013, for EP Patent Application No. 09730501.5, filed on Nov. 4, 2010, 5 pages. |
Supplementary Partial European Search Report dated Apr. 24, 2015, for EP Patent Application No. 12840013, filed Oct. 15, 2012, 6 pages. |
Number | Date | Country | |
---|---|---|---|
20190357936 A1 | Nov 2019 | US |
Number | Date | Country | |
---|---|---|---|
60820475 | Jul 2006 | US | |
60806417 | Jun 2006 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14532802 | Nov 2014 | US |
Child | 16168223 | US | |
Parent | 12925466 | Oct 2010 | US |
Child | 14532802 | US | |
Parent | 11567715 | Dec 2006 | US |
Child | 12925466 | US | |
Parent | 11551191 | Oct 2006 | US |
Child | 11567715 | US |